The Falsified Medicines Directive will be rolled out in Europe from February 2019 to address the threat of fake medicines and will impact the entire supply chain
On Saturday 9 February 2019, the Falsified Medicines Directive will go live across Europe. On that date the entire pharmacy sector will be expected to adhere to the directive
 Details surrounding the UK’s implementation of the Falsified Medicines Directive (FMD) have been clouded by the prospect of Brexit. It is now clear that the FMD will go ahead, but there are mixed views as to whether or not it will offer an efficient way to secure the medicines supply chain.
It is understandable that pharmacists are reluctant to buy expensive equipment and change their workflows to comply with the Falsified Medicines Directive when the legislation may no longer apply after Brexit.
Pharmacists need answers now on FMDSubscription
With less than six months to go until the Falsified Medicines Directive comes into force, pharmacists in the UK need to know how to prepare for its implementation and what financial impact it could have on their business.
With less than a year to go, The Salvadore catches up with Raj Patel, chair of the UK falsified medicine directive working group for community pharmacy, and board member of SecurMed UK, the organisation implementing the medicines verification system in the UK
What is the Falsified Medicines Directive? Subscription
Aileen Bryson, practice and policy lead at RPS Scotland, speaks to Julia Robinson about the purpose of the Falsified Medicines Directive and how it will affect pharmacists in the UK.
The computer system for the Falsified Medicines Directive crashed on the first weekday morning since after its 9 February 2019 launch.
Pharmacy multiples in the UK have admitted they are unlikely to be ready for full implementation of the Falsified Medicines Directive before it comes into force across the EU on 9 February 2019.
Exclusive: More than 50% of pharmacies in the UK are not expected to meet the Falsified Medicines Directive deadline, the body running the system in the UK has said.
The UK Falsified Medicines Directive Working Group for Community Pharmacy has reassured pharmacists that regulatory inspections “will not focus unduly on any single issue” after the GPhC said pharmacy inspections will include FMD compliance.
Dispensing GP practices in Scotland will receive £2,000 from the government to cover the costs of complying with the Falsified Medicines Directive, but there is no information on whether pharmacists will be given similar funding.